Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $66.4600 (-0.67%) ($66.2000 - $67.1000) on Wed. Mar. 21, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.46% (three month average) | RSI | 54 | Latest Price | $66.4600(-0.67%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX declines -0.3% a day on average for past five trading days. | Weekly Trend | BAX advances 0.2% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(57%) SPLV(52%) VYM(52%) XLP(50%) IVE(49%) | Factors Impacting BAX price | BAX will decline at least -0.73% in a week (0% probabilities). TLT(-19%) VIXM(-14%) GDXJ(-10%) DIA(-8%) UUP(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.73% (StdDev 1.46%) | Hourly BBV | 0 () | Intraday Trend | -0.7% | | | |
|
Resistance Level | $67.54 | 5 Day Moving Average | $67.12(-0.98%) | 10 Day Moving Average | $67.58(-1.66%) | 20 Day Moving Average | $67.54(-1.6%) | To recent high | -8% | To recent low | 6.2% | Market Cap | $33.907b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |